title: Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention?
authors.affiliation: Hubert Department of Global Health and the Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA; Cancer Prevention and Control Program, Winship Cancer Institute, Atlanta, GA; Emory Vaccine Center, Atlanta, GA. Electronic address: rbednar@emory.edu.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Bednarczyk
authors.affiliation: Hubert Department of Global Health and the Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
authors.forename: Daniella
authors.initials: D
authors.lastname: Figueroa-Downing
authors.affiliation: Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City KS.
authors.forename: Kevin
authors.initials: K
authors.lastname: Ault
mesh_terms: D018450:Disease Progression; D005260:Female; D006801:Humans; D053918:Papillomavirus Vaccines; D010353:Patient Education as Topic; D011322:Primary Prevention; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology*; D014626:Vaginal Smears; D002578:Uterine Cervical Dysplasia / Q000517:prevention & control / Q000821:virology
chemical_list: D053918:Papillomavirus Vaccines